Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves'

Chae Eun Lee1, Soo Hyun Choi2, Jin Sook Yoon3

  • 1Yonsei University College of Medicine, Seoul, Korea.

Abstract

Insights

Chemokines are downregulated in Graves' orbitopathy (GO) tissues. Their expression changes during adipogenesis and inflammation, suggesting a role in GO pathogenesis and potential use as biomarkers.

Area of Science:

  • Immunology
  • Endocrinology
  • Ophthalmology

Background:

  • Chemokines mediate autoimmune disease pathogenesis.
  • Graves' orbitopathy (GO) is an autoimmune condition affecting the eye.
  • Limited data exists on chemokine dynamics in GO.

Purpose of the Study:

  • Investigate chemokine and receptor expression in GO.
  • Analyze dynamics during orbital fibroblast adipogenesis and inflammation.

Main Methods:

  • Compared mRNA expression of chemokines in GO vs. non-GO orbital tissues (real-time PCR).
  • Induced adipogenesis in primary GO orbital fibroblasts.
  • Stimulated fibroblasts with IL-1β and TNF-α.
  • Analyzed chemokine and receptor mRNA expression.

Main Results:

  • Chemokines were downregulated in GO tissues (p < 0.05).
  • Adipogenesis initially increased chemokine/receptor mRNA, then decreased.
  • IL-1β and TNF-α stimulation upregulated chemokines/receptors.

Conclusions:

  • Chemokines show dynamic expression during adipogenesis and inflammation in GO.
  • Reduced chemokine expression in GO tissues may indicate a therapeutic window.
  • Chemokines and receptors are implicated in GO pathogenesis and could be GO biomarkers.